Acne Treatment Market Size to Surpass USD 15.70 Billion by 2030, exhibiting a CAGR of 5.1%

As per the report by Fortune Business Insights, the global acne treatment market size is projected to reach USD 15.70 Billion by 2030, at a CAGR of 5.1% during the forecast period

Pune, India, Aug. 01, 2023 (GLOBE NEWSWIRE) -- According to Fortune Business Insights, the global acne treatment market size was valued at USD 10.48 billion in 2022 and is projected to grow from USD 11.09 billion in 2023 to USD 15.70 billion by 2030, exhibiting a CAGR of 5.1% during the forecast period.

Acne is a condition of the skin where the hair follicles get plugged with dead skin and oil. This condition can be commonly seen among teenagers, although affecting people of all ages. The commonly used drugs for acne are retinoids, antibiotics, and retinoid-like drugs.

Fortune Business Insights™ mentioned this in a report titled “Acne Treatment Market, 2023-2030.”


Request a Free Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/sample/acne-treatment-market-103361


Key Industry Development:

March 2022: Galderma launched its breakthrough skincare cream, Twyneo, to treat moderate to severe facial acne to the U.S. market at the American Academy of Dermatology (AAD) Annual Meeting.

Key Takeaways:

  • The increasing prevalence of acne is the major driver of the market growth.

  • The rising demand for over-the-counter (OTC) acne treatments is also expected to boost market growth.

  • The technological advancements in acne treatments, such as the development of new topical and oral medications, are expected to create new opportunities for market growth.

  • The high cost of some acne treatments is a major challenge for market growth.

Discover the Leading Players Featured in the Report:

Leading Players In the Acne Treatment Market Are ABBVIE INC. (Ireland), Botanix Pharmaceuticals (Australia), GALDERMA (Switzerland), Bausch Health Companies Inc. (U.S.), GlaxoSmithKline Plc. (U.K.), Bayer AG (Germany), Johnson & Johnson Services, Inc. (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel),

Report Scope & Segmentation

Report Coverage

Details

Forecast Period

2023 to 2030

Forecast Period 2023 to 2030 CAGR

5.1%

2030 Value Projection

USD 15.70 Billion

Base Year

2022

Market Size in 2023

USD 11.09 Billion

Historical Data

2019-2021

No. of Pages

150

Segments Covered

By Product, Route of Administration, Age Group, Distribution Channel, and Region


Browse Complete Report Details: https://www.fortunebusinessinsights.com/acne-treatment-market-103361



Drivers & Restraints:

Increasing Occurrence of Acne Globally to Foster Market Growth

The occurrence of skin problems has significantly increased around the world. As a result, established and emerging nations in Asia Pacific, North America, and Europe are witnessing a rise in the number of patients choosing the treatment. The development of numerous acne therapy drugs, including antibiotics in oral and topical forms, retinoids, and isoprenoids has increased public knowledge of these medicines and the range of treatment choices available.